Pfizer Agrees to First Neurontin Lawsuit Settlement
This article is for subscribers only.
Pfizer Inc. agreed to pay about $400,000 to settle a lawsuit mid-trial that blamed its Neurontin epilepsy medicine for helping cause a Massachusetts man’s suicide, two people familiar with the accord said.
It’s the first settlement over a Neurontin-related suicide claim. Pfizer, the world’s largest drugmaker, agreed yesterday to resolve allegations by Hartley Shearer’s family in Boston federal court that its Warner-Lambert unit knew the drug posed a suicide risk and failed to disclose it to patients and doctors.